CD4 and HIV infectious disease: While a Canadian clinical trial evaluated adjunctive niacin therapy in HIV infection (32), aiming to counteract tryptophan depletion and immune hyperactivation caused by HIV infection and thus improve CD4+ T-cell recovery, results showed that niacin significantly reduced plasma kynurenine levels and modestly decreased CD4+ T-cell activation (33).